Complement activation and inhibition in wound healing

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Cazander, Gwendolyn ^a,b   Jukema, Gerrolt N ^c   Nibbering, Peter H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACHYROCLINE FLACCIDA EXTRACT; ALOE VERA EXTRACT; APEIBA TIBOURBOU EXTRACT; ARC 1905; ARTEMISIA DRACUNCULUS EXTRACT; ARTEMISIA MONTANA EXTRACT; ARTEMISIA PRINCEPS EXTRACT; ARTEMISIA RUBRIPES EXTRACT; ARTEMISIA TRIPARTITA EXTRACT; ASCOPHYLLUM NODOSUM EXTRACT; ASTRONIUM URUNDEUVA EXTRACT; AVICENNIA MARINA EXTRACT; BIOPHYTUM PETERSIANUM EXTRACT; BOSWELLIA SERRATA EXTRACT; BRIDELIA FERRUGINEA EXTRACT; COCHLOSPERMUM VITIFOLIUM EXTRACT; CROTON DRACO EXTRACT; ECULIZUMAB; EUGENIA MALACCENSIS EXTRACT; EUPATORIUM ARNOTTIANUM EXTRACT; EUPATORIUM BUNIIFOLIUM EXTRACT; EUTERPE PRECATORIA EXTRACT; GLYCINE MAX EXTRACT; GLYCYRRHIZA GLABRA EXTRACT; ISOPYRUM THALICTROIDES EXTRACT; JATROPHA MULTIFIDA EXTRACT; LITHRAEA MOLLEOIDES EXTRACT; MIROCOCEPT; OPILIA CELTIDIFOLIA EXTRACT; PIPER KADSURA EXTRACT; PLANT EXTRACT; POT 4; UNCLASSIFIED DRUG; UNINDEXED DRUG; COMPLEMENT;

ACHYROCLINE FLACCIDA; ACNE VULGARIS; ADDISON DISEASE; ALOE VERA; ALOPECIA; APEIBA TIBOURBOU; APHTHOUS STOMATITIS; ARTEMISIA MONTANA; ARTEMISIA PRINCEPS; ARTEMISIA RUBRIPES; ARTEMISIA TRIPARTITA; ARTHRITIS; ASCOPHYLLUM NODOSUM; ASTHMA; ASTRONIUM URUNDEUVA; ATHEROSCLEROSIS; AVICENNIA MARINA; BARK; BIOPHYTUM PETERSIANUM; BRIDELIA FERRUGINEA; BURN; CANDIDIASIS; CARDIOVASCULAR DISEASE; CELL DEATH; CHRONIC WOUND; COCHLOSPERMUM VITIFOLIUM; COLD INJURY; COLIC; COMPLEMENT ACTIVATION; COUGHING; CROHN DISEASE; CROTON DRACO; CYSTITIS; DECUBITUS; DIABETES MELLITUS; DIARRHEA; DRUG HYPERSENSITIVITY; DYSMENORRHEA; EDEMA; EUGENIA MALACCENSIS; EUPATORIUM ARNOTTIANUM; EUPATORIUM BUNIIFOLIUM; EUTERPE PRECATORIA; GASTROINTESTINAL DISEASE; GASTROINTESTINAL INFECTION; GASTROINTESTINAL SYMPTOM; GENITAL HERPES; HEADACHE; HEPATOBILIARY DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; IC 50; INFLAMMATION; ISCHIALGIA; ISOPYRUM THALICTROIDES; KIDNEY DISEASE; LICHEN PLANUS; LITHRAEA MOLLEOIDES; LIVER DISEASE; LUNG DISEASE; MALARIA; MEDICINAL PLANT; MUCOSA INFLAMMATION; MYALGIA; NEPHROLITHIASIS; NEURALGIA; OLIGOPHRENIA; OPILIA CELTIDIFOLIA; OSTEOARTHRITIS; PAIN; PIPER KADSURA; PLANT LEAF; PLANT ROOT; PLANT STEM; PRIORITY JOURNAL; PSORIASIS VULGARIS; RADIATION DERMATITIS; RESPIRATORY TRACT DISEASE; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RHIZOME; SEBORRHEIC DERMATITIS; SILICOSIS; SKIN ALLERGY; SKIN DISEASE; SKIN ULCER; SMALLPOX; SORE THROAT; SOYBEAN; STOMACH PAIN; STOMACH ULCER; SYMBIONT; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; TIC; TISSUE INJURY; TUBERCULOSIS; ULCER; ULCERATIVE COLITIS; UTERINE CERVICITIS; UTERUS BLEEDING; VOMITING; WOUND CARE; WOUND HEALING; WOUND HEALING IMPAIRMENT; WOUND INFECTION; ANIMAL; IMMUNOLOGY; METABOLISM;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HUMANS; WOUND HEALING;

MLCS; MLOWN;

EID: 84872790466     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/534291     Document Type: Review

References (113)

1. Baxter C. R., Immunologic reactions in chronic wounds. The American Journal of Surgery 1994 167 1 S12 S14 2-s2.0-0027941042 10.1016/0002-9610(94) 90004-3 (Pubitemid 124006957)
2. Jones S. G., Edwards R., Thomas D. W., Inflammation and wound healing: the role of bacteria in the immune-regulation of wound healing. Lower Extremity Wounds 2004 3 4 201 208
3. Park J. E., Barbul A., Understanding the role of immune regulation in wound healing. The American Journal of Surgery 2004 187 5 11S 16S 2-s2.0-2442595111 10.1016/S0002-9610(03)00296-4 (Pubitemid 38625982)
4. Chaby G., Senet P., Vaneau M., Martel P., Guillaume J. C., Meaume S., Téot L., Debure C., Dompmartin A., Bachelet H., Carsin H., Matz V., Richard J. L., Rochet J. M., Sales-Aussias N., Zagnoli A., Denis C., Guillot B., Chosidow O., Dressings for acute and chronic wounds: a systematic review. Archives of Dermatology 2007 143 10 1297 1304 2-s2.0-35348997934 10.1001/archderm.143.10.1297 (Pubitemid 47607683)
5. Ubbink D. T., Westerbos S. J., Nelson E. A., Vermeulen H., A systematic review of topical negative pressure therapy for acute and chronic wounds. British Journal of Surgery 2008 95 6 685 692 2-s2.0-44249107605 10.1002/bjs.6238
6. Cha J., Falanga V., Stem cells in cutaneous wound healing. Clinics in Dermatology 2007 25 1 73 78 2-s2.0-33846638398 10.1016/j.clindermatol.2006.10. 002 (Pubitemid 46178534)
7. Chen J. S., Wong V. W., Gurtner G. C., The therapeutic potential of bone marrow-derived mesenchymal cells for cutaneous wound healing. Frontiers in Immunology 2012 3 1 9
8. Martin P., Wound healing-aiming for perfect skin regeneration. Science 1997 276 5309 75 81 2-s2.0-0030934532 10.1126/science.276.5309.75 (Pubitemid 27161246)
9. Werner S., Grose R., Regulation of wound healing by growth factors and cytokines. Physiological Reviews 2003 83 3 835 870 2-s2.0-0038676258 (Pubitemid 36828927)
10. Eming S. A., Krieg T., Davidson J. M., Inflammation in wound repair: molecular and cellular mechanisms. Journal of Investigative Dermatology 2007 127 3 514 525 2-s2.0-33847020833 10.1038/sj.jid.5700701
11. Markiewski M. M., Lambris J. D., The role of complement in inflammatory diseases from behind the scenes into the spotlight. American Journal of Pathology 2007 171 3 715 727 2-s2.0-34548849117 10.2353/ajpath.2007.070166 (Pubitemid 47440971)
12. Yeh C. G., Marsh H. C. Jr., Carson G. R., Berman L., Concino M. F., Scesney S. M., Kuestner R. E., Skibbens R., Donahue K. A., Ip S. H., Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive Arthus reaction in rats. Journal of Immunology 1991 146 1 250 256 2-s2.0-0026071118
13. Wahl S. M., Arend W. P., Ross R., The effect of complement depletion of wound healing. American Journal of Pathology 1974 75 1 73 90 2-s2.0-0016367188
14. Hew B. E., Wehrhahn D., Fritzinger D. C., Vogel C. W., Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor. Toxicon 2012 60 632 647
15. Mulligan M. S., Yeh C. G., Rudolph A. R., Ward P. A., Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury. Journal of Immunology 1992 148 5 1479 1485 2-s2.0-0026567622
16. Henze U., Lennartz A., Hafemann B., Goldmann C., Kirkpatrick C. J., Klosterhalfen B., The influence of the C1-inhibitor BERINERT and the protein-free haemodialysate ACTIHAEMYL20% on the evolution of the depth of scald burns in a porcine model. Burns 1997 23 6 473 477 2-s2.0-0030666428 10.1016/S0305-4179(97)00019-3 (Pubitemid 27527097)
17. Begieneman M. P. V., Kubat B., Ulrich M. M. W., Hahn N. E., Stumpf-Stolker Y., Tempelaars M., Middelkoop E., Zeerleder S., Wouters D., van Ham M. S., Niessen H. W. M., Krijnen P. A. J., Prolonged C1 inhibitor administration improves local healing of burn wounds and reduces myocardial inflammation in a rat burn wound model. Journal of Burn Care and Research 2012 33 544 551
18. Suber F., Carroll M. C., Moore F. D. Jr., Innate response to self-antigen significantly exacerbates burn wound depth. Proceedings of the National Academy of Sciences of the United States of America 2007 104 10 3973 3977 2-s2.0-34247199895 10.1073/pnas.0609026104 (Pubitemid 47181563)
19. Chan R. K., Ibrahim S. I., Takahashi K., Kwon E., McCormack M., Ezekowitz A., Carroll M. C., Moore F. D., Austen W. G., The differing roles of the classical and mannose-binding lectin complement pathways in the events following skeletal muscle ischemia-reperfusion. Journal of Immunology 2006 177 11 8080 8085 2-s2.0-33751583216 (Pubitemid 44846326)
20. Neher M. D., Weckbach S., Flierl M. A., Huber-Lang M. S., Stahel P. F., Molecular mechanisms of inflammation and tissue injury after major trauma-is complement the 'bad guy?'. Journal of Biomedical Science 2011 18 1 6
21. Walport M. J., Complement (second of two parts). The New England Journal of Medicine 2001 344 15 1140 1144 2-s2.0-0035849176 10.1056/NEJM200104123441506 (Pubitemid 32285236)
22. Trouw L. A., Daha M. R., Role of complement in innate immunity and host defense. Immunology Letters 2011 138 1 35 37 2-s2.0-79957765079 10.1016/j.imlet.2011.02.014
23. Walport M. J., Complement (first of two parts). The New England Journal of Medicine 2001 344 14 1058 1066 2-s2.0-0035810399 10.1056/NEJM200104053441406 (Pubitemid 32267977)
24. Strey C. W., Markiewski M., Mastellos D., Tudoran R., Spruce L. A., Greenbaum L. E., Lambris J. D., The proinflammatory mediators C3a and C5a are essential for liver regeneration. Journal of Experimental Medicine 2003 198 6 913 923 2-s2.0-0141449968 10.1084/jem.20030374 (Pubitemid 37152928)
25. Bossi F., Rizzi L., Bulla R., Tripodo C., Guarnotta C., Novati F., Ghebrehiwet B., Tedesco F., C1q induces in vivo angiogenesis and promotes wound healing. Molecular Immunology 2011 48 1676 1677
26. Sinno H., Malholtra M., Lutfy J., Jardin B., Winocour S., Brimo F., Beckman L., Watters K., Philip A., Williams B., Prakash S., Topical application of complement C3 in collagen formulation increases early wound healing. Journal of Dermatological Treatment. In press
27. Balslev E., Thomsen H. K., Danielsen L., Sheller J., Garred P., The terminal complement complex is generated in chronic leg ulcers in the absence of protectin (CD59). Acta Pathologica, Microbiologica, et Immunologica Scandinavica 1999 107 11 997 1004 2-s2.0-0032737849
28. Schmidtchen A., Degradation of antiproteinases, complement and fibronectin in chronic leg ulcers. Acta Dermato-Venereologica 2000 80 3 179 184 2-s2.0-0033816790
29. Jacobsen J. N., Andersen A. S., Sonnested M. K., Laursen I., Jorgensen B., Krogfelt K. A., Investigating the humoral immune response in chronic venous leg ulcer patients colonised with Pseudomonas aeruginosa. International Wound Journal 2011 8 1 33 43 2-s2.0-78751691645 10.1111/j.1742-481X.2010.00741.x
30. Van de Goot F., Krijnen P. A. J., Begieneman M. P. V., Ulrich M. M. W., Middelkoop E., Niessen H. W. M., Acute inflammation is persistent locally in burn wounds: a pivotal role for complement and C-reactive protein. Journal of Burn Care and Research 2009 30 2 274 280 2-s2.0-62549105264 10.1097/BCR. 0b013e318198a252
31. Machens H. G., Pabst A., Dreyer M., Gliemroth J., Görg S., Bahlmann L., Klaus S., Kaun M., Krü;ger S., Mailänder P., C3a levels and occurrence of subdermal vascular thrombosis are age-related in deep second-degree burn wounds. Surgery 2006 139 4 550 555 2-s2.0-33646041879 10.1016/j.surg.2005.09.001
32. Wan K. C., Lewis W. H. P., Leung P. C., Chien P., Hung L. K., A longitudinal study of C3, C3d and factor Ba in burn patients in Hong Kong Chinese. Burns 1998 24 3 241 244 2-s2.0-0032077694 10.1016/S0305-4179(98)00013-8 (Pubitemid 28316305)
33. Radke A., Mottaghy K., Goldmann C., Khorram-Sefat R., Kovacs B., Janssen A., Klosterhalfen B., Hafemann B., Pallua N., Kirschfink M., C1 inhibitor prevents capillary leakage after thermal trauma. Critical Care Medicine 2000 28 9 3224 3232 2-s2.0-0033801237
34. Antoniu S. A., Therapeutic approaches in hereditary angioedema. Clinical Reviews in Allergy & Immunology 2011 41 114 122
35. Davis B., Bernstein J. A., Conestat alfa for the treatment of angioedema attacks. Therapeutic and Clinical Risk Management 2011 7 265 273
36. Emlen W., Li W., Kirschfink M., Therapeutic complement inhibition: new developments. Seminars in Thrombosis and Hemostasis 2010 36 6 660 668 2-s2.0-77957567053 10.1055/s-0030-1262888
37. Martel C., Granger C. B., Ghitescu M., Stebbins A., Fortier A., Armstring P. W., Bonnefoy A., Theroux P., Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the assessment of Pexelizumab in acute myocardial infarction (APEX-AMI) trial. American Heart Journal 2012 164 43 51 (Pubitemid 46041725)
38. Ricklin D., Lambris J. D., Compstatin: a complement inhibitor on its way to clinical application. Advances in Experimental Medicine and Biology 2008 632 273 292 2-s2.0-52649116114
39. Banz Y., Hess O. M., Robson S. C., Csizmadia E., Mettler D., Meier P., Haeberli A., Shaw S., Smith R. A., Rieben R., Attenuation of myocardial reperfusion injury in pigs by Mirococept, a membrane-targeted complement inhibitor derived from human CR1. Cardiovascular Research 2007 76 3 482 493 2-s2.0-35548936851 10.1016/j.cardiores.2007.07.016 (Pubitemid 350007457)
40. http://www.controlled-trials.com/ISRCTN49958194
41. Fridkis-Hareli M., Storek M., Mazsaroff I., Risitano A. M., Lundberg A. S., Horvath C. J., Holers V. M., Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases. Blood 2011 118 4705 4713
42. Atkinson C., Song H., Lu B., Qiao F., Burns T. A., Holers V. M., Tsokos G. C., Tomlinson S., Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection. Journal of Clinical Investigation 2005 115 9 2444 2453 2-s2.0-24644487357 10.1172/JCI25208 (Pubitemid 41266206)
43. Sherman R. A., Hall M. J. R., Thomas S., Medicinal maggots: an ancient remedy for some contemporary afflictions. Annual Review of Entomology 2000 45 55 81 2-s2.0-0034083921 10.1146/annurev.ento.45.1.55 (Pubitemid 30187854)
44. Steenvoorde P., Jukema G. N., The antimicrobial activity of maggots: in-vivo results. Journal of Tissue Viability 2004 14 3 97 101 2-s2.0-14544271061
45. Jukema G. N., Menon A. G., Bernards A. T., Steenvoorde P., Rastegar A. T., Van Dissel J. T., Amputation-sparing treatment by nature: «surgical» maggots revisited. Clinical Infectious Diseases 2002 35 12 1566 1571 2-s2.0-0037115231 10.1086/344904 (Pubitemid 36020704)
46. Dumville J. C., Worthy G., Bland J. M., Cullum N., Dowson C., Iglesias C., Mitchell J. L., Nelson E. A., Soares M. O., Torgerson D. J., Larval therapy for leg ulcers (VenUS II): randomised controlled trial. British Medical Journal 2009 338 b773 2-s2.0-63149121187 10.1136/bmj.b773
47. FDA,. http://www.accessdata.fda.gov/cdrh-docs/pdf7/K072438.pdf
48. Cazander G., van Veen K. E. B., Bernards A. T., Jukema G. N., Do maggots have an influence on bacterial growth? A study on the susceptibility of strains of six different bacterial species to maggots of Lucilia sericata and their excretions/secretions. Journal of Tissue Viability 2009 18 3 80 87 2-s2.0-67650083116 10.1016/j.jtv.2009.02.005
49. Cazander G., Van De Veerdonk M. C., Vandenbroucke-Grauls C. M. J. E., Schreurs M. W. J., Jukema G. N., Maggot excretions inhibit biofilm formation on biomaterials. Clinical Orthopaedics and Related Research 2010 468 10 2789 2796 2-s2.0-77957337211 10.1007/s11999-010-1309-5
50. van der Plas M. J. A., van der Does A. M., Baldry M., Dogterom-Ballering H. C. M., van Gulpen C., van Dissel J. T., Nibbering P. H., Jukema G. N., Maggot excretions/secretions inhibit multiple neutrophil pro-inflammatory responses. Microbes and Infection 2007 9 4 507 514 2-s2.0-33947195706 10.1016/j.micinf. 2007.01.008 (Pubitemid 46436548)
51. Chambers L., Woodrow S., Brown A. P., Harris P. D., Phillips D., Hall M., Church J. C. T., Pritchard D. I., Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. British Journal of Dermatology 2003 148 1 14 23 2-s2.0-0037240611 10.1046/j.1365-2133.2003.04935.x (Pubitemid 36114856)
52. Horobin A. J., Shakesheff K. M., Pritchard D. I., Promotion of human dermal fibroblast migration, matrix remodelling and modification of fibroblast morphology within a novel 3D model by Lucilia sericata larval secretions. Journal of Investigative Dermatology 2006 126 6 1410 1418 2-s2.0-33745548601 10.1038/sj.jid.5700256 (Pubitemid 43997926)
53. Cazander G., Schreurs M. W. J., Renwarin L., Dorresteijn C., Hamann D., Jukema G. N., Maggot excretions affect the human complement system. Wound Repair and Regeneration 2012 20 6 879 886
54. Lambris J. D., Ricklin D., Geisbrecht B. V., Complement evasion by human pathogens. Nature Reviews Microbiology 2008 6 2 132 142 2-s2.0-38349048514 10.1038/nrmicro1824
55. Blom A. M., Hallström T., Riesbeck K., Complement evasion strategies of pathogens-Acquisition of inhibitors and beyond. Molecular Immunology 2009 46 14 2808 2817 2-s2.0-68249086824 10.1016/j.molimm.2009.04.025
56. Jongerius I., Puister M., Wu J., Ruyken M., Van Strijp J. A. G., Rooijakkers S. H. M., Staphylococcal complement inhibitor modulates phagocyte responses by dimerization of convertases. Journal of Immunology 2010 184 1 420 425 2-s2.0-73949087351 10.4049/jimmunol.0902865
57. García-Hernández P., Rodero M., Cuéllar C., Anisakis simplex: the activity of larval products on the complement system. Experimental Parasitology 2007 115 1 8
58. Hellwage J., Meri T., Heikkilä T., Alitalo A., Panelius J., Lahdenne P., Seppälä I. J. T., Meri S., The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. Journal of Biological Chemistry 2001 276 11 8427 8435 2-s2.0-0035896505 10.1074/jbc.M007994200
59. Pietikäinen J., Meri T., Blom A. M., Meri S., Binding of the complement inhibitor C4b-binding protein to Lyme disease borreliae. Molecular Immunology 2010 47 6 1299 1305 2-s2.0-77149129877 10.1016/j.molimm.2009.11.028
60. Mika A., Reynolds S. L., Mohlin F. C., Willis C., Swe P. M., Pickering D. A., Halilovic V., Wijeyewickrema L. C., Pike R. N., Blom A. M., Kemp D. J., Fischer K., Novel scabies mite serpins inhibit the three pathways of the human complement system. PLoS One 2012 7 7 1
61. Fernández T., Cerdá Zolezzi P., Risco E., Martino V., López P., Clavin M., Hnatyszyn O., Canigueral S., Hajos S., Ferraro G., Alvarez E., Immunomodulating properties of Argentine plants with ethnomedicinal use. Phytomedicine 2002 9 6 546 552 2-s2.0-0036746179
62. 'T Hart L. A., Van den Berg A. J. J., Kuis L., Van Dijk H., Labadie R. P., An anti-complementary polysaccharide with immunological adjuvant activity from the leaf parenchyma gel of Aloe vera. Planta Medica 1989 55 6 509 512 2-s2.0-0024852550 (Pubitemid 20059689)
63. Surjushe A., Vasani R., Saple D., Aloe vera: a short review. Indian Journal of Dermatology 2008 53 4 163 166 2-s2.0-58149472002 10.4103/0019-5154. 44785
64. Lasure A., Van Poel B., Pieters L., Claeys M., Gupta M., Berghe D. V., Vlietinck A. J., Complement-inhibiting properties of Apeiba tibourbou. Planta Medica 1994 60 3 276 277 2-s2.0-0028242708 10.1055/s-2006-959475 (Pubitemid 24207725)
65. Inngjerdingen K. T., Coulibaly A., Diallo D., Michaelsen T. E., Paulsen B. S., A complement fixing polysaccharide from Biophytum petersianum klotzsch, a medicinal plant from Mali, West Africa. Biomacromolecules 2006 7 1 48 53 2-s2.0-31544465210 10.1021/bm050330h (Pubitemid 43154477)
66. Gancevici G. G., Popescu C., Natural inhibitors of complement. III. Inactivation of the complement cascade in vitro by vegetal spices (Ocimum basilicum, Artemisia dracunculus and Thymus vulgaris). Archives Roumaines de Pathologie Experimentale et de Microbiologie 1987 46 4 321 331 2-s2.0-0023427292
67. Moon H. I., Jung S., Lee Y. C., Lee J. H., Anticomplement activity of various solvent extracts from Korea local artemisia spp. Immunopharmacology and Immunotoxicology 2012 34 1 95 97
68. Jung S., Lee J. H., Lee Y. C., Moon H. I., Inhibition effects of isolated compounda from Artemisia rubripes Nakai of the classical pathway on the complement system. Immunopharmacology and Immunotoxicology 2012 34 2 244 246
69. Tissot B., Montdargent B., Chevolot L., Varenne A., Descroix S., Gareil P., Daniel R., Interaction of fucoidan with the proteins of the complement classical pathway. Biochimica et Biophysica Acta 2003 1651 1-2 5 16 2-s2.0-0344475080 10.1016/S1570-9639(03)00230-9 (Pubitemid 38234548)
70. Cumashi A., Ushakova N. A., Preobrazhenskaya M. E., D'Incecco A., Piccoli A., Totani L., Tinari N., Morozevich G. E., Berman A. E., Bilan M. I., Usov A. I., Ustyuzhanina N. E., Grachev A. A., Sanderson C. J., Kelly M., Rabinovich G. A., Iacobelli S., Nifantiev N. E., A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 2007 17 5 541 552 2-s2.0-34447333662 10.1093/glycob/cwm014 (Pubitemid 47049941)
71. Deharo E., Baelmans R., Gimenez A., Quenevo C., Bourdy G., In vitro immunomodulatory activity of plants used by the Tacana ethnic group in Bolivia. Phytomedicine 2004 11 6 516 522 2-s2.0-4744354399 10.1016/j.phymed.2003.07.007 (Pubitemid 39312628)
72. Fang X., Jiang B., Wang X., Purification and partial characterization of an acidic polysaccharide with complement fixing ability from the stems of Avicennia Marina. Journal of Biochemistry and Molecular Biology 2006 39 5 546 555 2-s2.0-33750795628 (Pubitemid 44714535)
73. Togola A., Inngjerdingen M., Diallo D., Barsett H., Rolstad B., Michaelsen T. E., Paulsen B. S., Polysaccharides with complement fixing and macrophage stimulation activity from Opilia celtidifolia, isolation and partial characterisation. Journal of Ethnopharmacology 2007 115 3 423 431 2-s2.0-37449017052 10.1016/j.jep.2007.10.017
74. Ammon H. P. T., Modulation of the immune system by Boswellia serrata extracts and boswellic acids. Phytomedicine 2010 17 11 862 867 2-s2.0-77955983183 10.1016/j.phymed.2010.03.003
75. Ammon H. P. T., Boswellic acids in chronic inflammatory diseases. Planta Medica 2006 72 12 1100 1116 2-s2.0-33750391774 10.1055/s-2006-947227 (Pubitemid 44638909)
76. Cimanga K., De Bruyne T., Apers S., Pieters L., Totté J., Kambu K., Tona L., Bakana P., Van Ufford L. Q., Beukelman C., Labadie R., Vlietinck A. J., Complement-inhibiting constituents of Bridelia ferruginea stem bark. Planta Medica 1999 65 3 213 217 2-s2.0-0033011184 10.1055/s-1999-14059 (Pubitemid 29186072)
77. Sánchez-Salgado J. C., Castillo-España P., Ibarra-Barajas M., Villalobos-Molina R., Estrada-Soto S., Cochlospermum vitifolium induces vasorelaxant and antihypertensive effects mainly by activation of NO/cGMP signaling pathway. Journal of Ethnopharmacology 2010 130 3 477 484 2-s2.0-77954955072 10.1016/j.jep.2010.05.037
78. Tsacheva I., Rostan J., Iossifova T., Vogler B., Odjakova M., Navas H., Kostova I., Kojouharova M., Kraus W., Complement inhibiting properties of dragon's blood from Croton draco. Zeitschrift fur Naturforschung C 2004 59 7-8 528 532 2-s2.0-4143089247 (Pubitemid 39098551)
79. Diallo D., Paulsen B. S., Liljebäck T. H. A., Michaelsen T. E., Polysaccharides from the roots of Entada africana Guill. et Perr., Mimosaceae, with complement fixing activity. Journal of Ethnopharmacology 2001 74 2 159 171 2-s2.0-0035130815 10.1016/S0378-8741(00)00361-5 (Pubitemid 32141098)
80. Locher C. P., Burch M. T., Berestecky J., Davis H., Van Poel B., Lasure A., Vanden Berghe D. A., Vlietinck A. J., Mower H. F., Anti-microbial activity and anti-complement activity of extracts obtained from selected Hawaiian medicinal plants. Journal of Ethnopharmacology 1995 49 1 23 32 2-s2.0-0029567966 10.1016/0378-8741(95)01299-0 (Pubitemid 26010736)
81. Kulkarni A. P., Kella Way L. A., Kotwal G. J., Herbal complement inhibitors in the treatment of neuroinflammation: future strategy for neuroprotection. Annals of the New York Academy of Sciences 2005 1056 413 429 2-s2.0-29744441170 10.1196/annals.1352.020 (Pubitemid 43030996)
82. Kim H. J., Lim J. S., Kim W. K., Kim J. S., Soyabean glyceollins: biological effects and relevance to human health. The Proceedings of the Nutritional Society 2012 71 1 166 174
83. Kawakami F., Shimoyama Y., Ohtsuki K., Characterization of complement C3 as a glycyrrhizin (GL)-binding protein and the phosphorylation of C3 α by CK-2, which is potently inhibited by GL and glycyrrhetinic acid in vitro. Journal of Biochemistry 2003 133 2 231 237 2-s2.0-0037303572 10.1093/jb/mvg028 (Pubitemid 36362483)
84. Nassiri Asl M., Hosseinzadeh H., Review of pharmacological effects of glycyrrhiza sp. and its bioactive compounds. Phytotherapy Research 2008 22 6 709 724 2-s2.0-46849110600 10.1002/ptr.2362 (Pubitemid 351955567)
85. Kosasi S., 'T Hart L. A., Van Dijk H., Labadie R. P., Inhibitory activity of Jatropha multifida latex on classical complement pathway activity in human serum mediated by a calcium-binding proanthocyanidin. Journal of Ethnopharmacology 1989 27 1-2 81 89 2-s2.0-0024787410 10.1016/0378-8741(89) 90080-9 (Pubitemid 20018063)
86. Chiou W. F., Peng C. H., Chen C. F., Chou C. J., Anti-inflammatory properties of piperlactam S: modulation of complement 5a-induced chemotaxis and inflammatory cytokines production in macrophages. Planta Medica 2003 69 1 9 14 2-s2.0-0344643465 10.1055/s-2003-37041 (Pubitemid 36228450)
87. Miguel O. G., Calixto J. B., Santos A. R. S., Messana I., Ferrari F., Cechinel Filho V., Pizzolatti M. G., Yunes R. A., Chemical and preliminary analgesic evaluation of geraniin and furosin isolated from Phyllanthus sellowianus. Planta Medica 1996 62 2 146 149 2-s2.0-0030011432 10.1055/s-2006-957838 (Pubitemid 26163219)
88. Al-Sereiti M. R., Abu-Amer K. M., Sen P., Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian Journal of Experimental Biology 1999 37 2 124 130 2-s2.0-0032957268 (Pubitemid 29103965)
89. Peake P. W., Pussell B. A., Martyn P., Timmermans V., Charlesworth J. A., The inhibitory effect of rosmarinic acid on complement involves the C5 convertase. International Journal of Immunopharmacology 1991 13 7 853 857 2-s2.0-0026012298
90. Diallo D., Paulsen B. S., Liljebäck T. H. A., Michaelsen T. E., The malian medicinal plant Trichilia emetica; studies on polysaccharides with complement fixing ability. Journal of Ethnopharmacology 2003 84 2-3 279 287 2-s2.0-0037298399 10.1016/S0378-8741(02)00330-6 (Pubitemid 36324268)
91. Lekowski R., Collard C. D., Reenstra W. R., Stahl G. L., Ulex europaeus agglutinin II (UEA-II) is a novel, potent inhibitor of complement activation. Protein Science 2001 10 2 277 284 2-s2.0-0035101081 10.1110/ps.26401 (Pubitemid 32225647)
92. Santos Araujo Mdo C., Farias I. L., Gutierres J., Dalmora S. L., Flores N., Farias J., De Cruz I., Chiesa J., Morsch V. M., Schetinger M. R. C., Uncaria tomentosa-Adjuvant treatment for breast cancer: clinical trial. Evidence-Based Complementary and Alternative Medicine 2012 2012 8 676984 10.1155/2012/676984
93. Kiyohara H., Cyong J. C., Yamada H., Structure and anti-complementary activity of pectic polysaccharides isolated from the root of Angelica acutiloba Kitagawa. Carbohydrate Research 1988 182 2 259 275 2-s2.0-0024116101
94. Yamada H., Ra K. S., Kiyohara H., Cyong J. C., Otsuka Y., Structural characterisation of an anti-complementary pectic polysaccharide from the roots of Bupleurum falcatum L. Carbohydrate Research 1989 189 209 226 2-s2.0-0024970659
95. Nergard C. S., Kiyohara H., Reynolds J. C., Thomas-Oates J. E., Matsumoto T., Yamada H., Patel T., Petersen D., Michaelsen T. E., Diallo D., Paulsen B. S., Structure and Structure-activity relationships of three mitogenic and complement fixing pectic arabinogalactans from the malian antiulcer plants Cochlospermum tinctorium A. Rich and Vernonia kotschyana sch. bip. ex walp. Biomacromolecules 2006 7 1 71 79 2-s2.0-31544470322 10.1021/bm050355g (Pubitemid 43154480)
96. Kulkarni A. P., Ghebremariam Y. T., Kotwal G. J., Curcumin inhibits the classical and the alternate pathways of complement activation. Annals of the New York Academy of Sciences 2005 1056 100 112 2-s2.0-29744460451 10.1196/annals.1352.007 (Pubitemid 43030970)
97. Chung I. M., Song H. K., Kim S. J., Moon H. I., Anticomplement activity of polyacetylenes from leaves of Dendropanax morbifera Leveille. Phytotherapy Research 2011 25 5 784 786 2-s2.0-79955527116 10.1002/ptr.3336
98. Min B. S., Lee S. Y., Kim J. H., Lee J. K., Kim T. J., Kim D. H., Kim Y. H., Joung H., Lee H. K., Nakamura N., Miyashiro H., Hattori M., Anti-complement activity of constituents from the stem-bark of Juglans mandshurica. Biological and Pharmaceutical Bulletin 2003 26 7 1042 1044 2-s2.0-1542392751 (Pubitemid 41685438)
99. Moon H. I., Lee J. H., Lee Y. C., Inhibitory effects of organic solvent extracts from Korean local plants of complement classical pathway. Immunopharmacology and Immunotoxicology 2012 34 2 12 14
100. Lee S. Y., Min B. S., Kim J. H., Lee J., Kim T. J., Kim C. S., Kim Y. H., Lee H. K., Flavonoids from the leaves of Litsea japonica and their anti-complement activity. Phytotherapy Research 2005 19 4 273 276 2-s2.0-23244459884 10.1002/ptr.1453 (Pubitemid 41098117)
101. Jung K. Y., Oh S. R., Park S. H., Lee I. S., Ahn K. S., Lee J. J., Lee H. K., Anti-complement activity of tiliroside from the flower buds of Magnolia fargesii. Biological and Pharmaceutical Bulletin 1998 21 10 1077 1078 2-s2.0-0142220385 (Pubitemid 28513986)
102. Thabrew M. I., De Silva K. T. D., Labadie R. P., De Bie P. A. F., Van Der Berg B., Immunomodulatory activity of three Sri-Lankan medicinal plants usd in hepatic disorders. Journal of Ethnopharmacology 1991 33 1-2 63 66 2-s2.0-0025878748
103. Lee J. G., Baek S. H., Lee Y. Y., Park S. Y., Park J. H., Anti-complementary ginsenosides isolated from processed ginseng. Biological and Pharmaceutical Bulletin 2011 34 6 898 900 2-s2.0-79958016306 10.1248/bpb.34.898
104. Si C. L., Deng X. J., Liu Z., Kim J. K., Bae Y. S., Studies on the phenylethanoid glycosides with anti-complement activity from Paulownia tomentosa var. tomentosa wood. Journal of Asian Natural Products Research 2008 10 11 1003 1008 2-s2.0-56749157730 10.1080/10286020802242364
105. Huang Y., De Bruyne T., Apers S., Ma Y., Claeys M., Vanden Berghe D., Pieters L., Vlietinck A., Complement-inhibiting cucurbitacin glycosides from Picria fel-terrae. Journal of Natural Products 1998 61 6 757 761 2-s2.0-0031845388 10.1021/np9705773 (Pubitemid 28317136)
106. Moon H. I., Lee Y. C., Lee J. H., Isolated compounds from Sorghum bicolor L. Inhibit the classical pathway of the complement. Immunopharmacology and Immunotoxicology 2012 34 2 299 302
107. Apers S., Huang Y., Van Miert S., Dommisse R., Berghe D. V., Pieters L., Vlietinck A., Characterisation of new oligoglycosidic compounds in two Chinese medicinal herbs. Phytochemical Analysis 2002 13 4 202 206 2-s2.0-0035988761 10.1002/pca.642 (Pubitemid 34823266)
108. Schmitt J., Roderfeld M., Sabrane K., Zhang P., Tian Y., Mertns J. C., Frei P., Stieger B., Weber A., Müllhaupt B., Roeb E., Geier A., Complement factor C5 deficiency significantly delays the progression of biliary fibrosis in bile-duct-ligated mice. Biochemical and Biophysical Research Communications 2012 418 445 450
109. Morgan B. P., Harris C. L., Complement therapeutics; history and current progress. Molecular Immunology 2003 40 2-4 159 170 2-s2.0-0041563747 10.1016/S0161-5890(03)00111-1 (Pubitemid 36959825)
110. Banda N. K., Levitt B., Glogowska M. J., Thurman J. M., Takahashi K., Stahl G. L., Tomlinson S., Arend W. P., Holers V. M., Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice. Journal of Immunology 2009 183 9 5928 5937 2-s2.0-75149162850 10.4049/jimmunol.0901826
111. Greinacher A., Friesecke S., Abel P., Dressel A., Stracke S., Fiene M., Ernst F., Selleng K., Weissenborn K., Schmidt B. M., Schiffer M., Felix S. B., Lerch M. M., Kielstein J. T., Mayerle J., Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial. The Lancet 2011 378 1166 1173
112. Woodruff T. M., Nandakumar K. S., Tedesco F., Inhibiting the C5-C5a receptor axis. Molecular Immunology 2011 48 14 1631 1642 2-s2.0-79960465027 10.1016/j.molimm.2011.04.014
113. Van der Plas M. J. A., Jukema G. N., Wai S. W., Dogterom-Ballering H. C. M., Lagendijk E. I., Van Gulpen C., Van Dissel J. T., Bloemberg G. V., Nibbering P. H., Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 2008 61 1 117 122 2-s2.0-37549058404 10.1093/jac/dkm407